#bms-986165

Top Pharma News of the Week – September 17th

All The Most Important Pharmaceutical News Stories Of The Week – September 2018 – Week # 3 Gilead and Galapagos Announce Filgotinib Meets Primary and All Key Secondary Endpoints in First Phase 3 Study in Rheumatoid Arthritis

September 11, 2018

Gilead Sciences, Inc. and Galapagos NV have announced that FINCH 2, a global, randomized, placebo-controlled, Phase 3 study of filgotinib, an…